A Medical Device Daily

Cyberkinetics Neurotechnology Systems (Foxborough, Massachusetts), a neurotechnology company developing neurostimulation and neural sensing products designed to restore function, said that it has been issued U.S. Patent No. 7,199,110, titled "Method of Treatment for Spinal Cord Injury," by the U.S. Patent and Trademark Office.

The patent relates to the company's Andara Oscillating Field Stimulator (OFS) Therapy neural stimulation technology platform.

Timothy Surgenor, president/CEO of Cyberkinetics, said, "In February 2007, Cyberkinetics filed a Humanitarian Device Exemption to market the Andara OFS System to treat people with spinal cord injuries within 18 days following their injuries [Medical Device Daily, Feb. 23, 2007]. This new patent covers the use of Cyberkinetics' Andara OFS System in combination with a growth factor, which may ultimately enable us to treat people with spinal cord and other nervous system injuries suffered months or years earlier."

The company reports that its intellectual property portfolio now includes five patents issued and more than 50 pending, covering systems, methods, devices and compounds for nerve repair, as well as neural interface technologies for diagnostic, therapeutic and functional restoration products.